Medacta Group SA Capital Reinvestment Ratio
Medacta Group SA capital reinvestment ratio. Medacta Group SA (MOVE) has a Capital Reinvestment Ratio of 0.76x as of June 2025, meaning it reinvests 1% of its operating cash flow (CHF72.95 Million) in capital expenditures (CHF55.51 Million). See Medacta Group SA free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Medacta Group SA (2016–2024)
Capital reinvestment ratio of Medacta Group SA from 2016 to 2024. This chart tracks Medacta Group SA's Capital Reinvestment Ratio across 9 annual periods. See Medacta Group SA leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Medacta Group SA Capital Reinvestment Ratio by Year (2016–2024)
Medacta Group SA capital reinvestment ratio by year from 2016 to 2024. For the full cash flow conversion analysis, see MOVE cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.98x | CHF107.14 Million | CHF104.69 Million | ▼ -10.7% |
| 2023 | 1.09x | CHF75.13 Million | CHF82.22 Million | ▲ +27.4% |
| 2022 | 0.86x | CHF73.51 Million | CHF63.16 Million | ▼ -0.1% |
| 2021 | 0.86x | CHF54.06 Million | CHF46.49 Million | ▲ +87.8% |
| 2020 | 0.46x | CHF59.59 Million | CHF27.29 Million | ▼ -52.9% |
| 2019 | 0.97x | CHF42.63 Million | CHF41.47 Million | ▲ +17.2% |
| 2018 | 0.83x | CHF66.41 Million | CHF55.13 Million | ▲ +6.8% |
| 2017 | 0.78x | CHF51.59 Million | CHF40.11 Million | ▲ +54.8% |
| 2016 | 0.50x | CHF56.31 Million | CHF28.29 Million | — |